Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.
Trial record 1 of 1 for:    SYNCHRONY Duvelisib
Previous Study | Return to List | Next Study

Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02292225
Recruitment Status : Terminated (The scope of the program has been reduced to focus resources on studies which can potentially enable the registration of duvelisib.)
First Posted : November 17, 2014
Last Update Posted : October 16, 2018
Information provided by (Responsible Party):
Verastem, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 2016
Actual Study Completion Date : November 2016